Sun Pharma on Sunday announced it will acquire 100% of Ranbaxy in an all-stock transaction valued at $4 billion.
Dr. Reddy's Labs announced that it has launched Sumatriptan Injection USP, Autoinjector System 6-mg/0.5-mL, a generic version of Imitrex STATdose Pen (sumatriptan succinate) 6-mg/0.5-mL.
Ranbaxy Labs is celebrating the 20th anniversary of its operations in Ukraine, the Indian generic drug maker said Wednesday.
Indian drug maker Dr. Reddy's Labs had sales of $536 million in second quarter 2014 and profits of $110 million, the company said.
Ranbaxy Labs had global sales of $447.6 million in third quarter 2013, compared with $434.6 million in third quarter 2012, the Indian drug maker said Tuesday.
Ranbaxy Labs recently marked the 20th anniversary of its operations in Russia, the India-based generic drug company announced.
Indian drug maker Dr. Reddy's Labs has launched a generic treatment for epilepsy, the company said.
Dr. Reddy’s has announced the appointment of Dr. Sripada Chandrasekhar as the president and global head of human resources; he will also be a member of Dr. Reddy’s Management Council.
Dr. Reddy's Labs and Fujifilm have terminated a deal to market generic drugs in Japan, Dr. Reddy's said.
Generic drug maker Dr. Reddy's Labs will move into a new North America headquarters and set up new laboratory space later this year, the company said Tuesday.
Indian generic drug maker Dr. Reddy's Labs has appointed G.V. Prasad as chairman of the company, Dr. Reddy's said.
Dr. Reddy's has launched a drug for treating acne, the company said Friday.
Generic drug maker Dr. Reddy's Labs has launched a drug used to treat certain cancers, the company said Tuesday.
Ranbaxy Labs will market a drug for depression under an agreement with another company, the drug maker said Tuesday.
Dr. Reddy's has launched a drug used for treating allergies, the generic drug maker said Friday.
Dr. Reddy's Labs has launched a generic drug for treating baldness, the Indian drug maker said.
Dr. Reddy's Labs has appointed a new CFO and head of its North America business, the generic drug maker said.
Ranbaxy Labs has recalled more than three dozen lots of its generic version of a cholesterol-lowering statin drug due to the possible presence of foreign particles, the company said.
Drug maker Dr. Reddy's Labs has launched a generic antibiotic drug, the company said Thursday.
A new poll conducted by the Financial Times and Harris Poll found that worry over...